河内五

越南河内五分彩挂机计划_河内5分彩单双大小路珠_越南河内五分彩历史号码

Vision for Life

DEVELOPING ONE-TIME GENE THERAPIES FOR EYE DISEASES

Welcome to

Gyroscope

We are discovering and developing innovative medicines to preserve people’s sight and fight the devastating impact of blindness around the world. Our ultimate goal for our patients is – Vision For Life.

 

A new era of medicine

Gyroscope was founded to explore the convergence of advancements made in the understanding of the complement system’s impact on eye disease, the genetic basis of age-related macular degeneration (AMD) and gene therapy as a mode of sustained treatment delivery. 

Our People

Our achievements would not be possible without the outstanding team that make up Gyroscope.

Gene Therapies

We are developing gene therapies beyond rare disease.

Science

At Gyroscope, science is at the core of everything we do.

Delivery

Developing surgical devices and procedures designed to deliver one-time ocular gene therapies.

An unmet

Medical Need

Age-related macular degeneration is a leading cause of irreversible blindness in the elderly. Today there is no approved treatment for the atrophic form of the disease.

Our global management and scientific teams have extensive experience in gene therapy and drug development, particularly in the field of ophthalmology, and have served in leadership roles at multiple innovative biotech and pharmaceutical companies.

Through our delivery system we also have significant surgical device development and surgeon training capabilities.

our approach to

partnering

With world-class expertise in gene therapy and drug development, particularly in the field of ophthalmology, Gyroscope is committed to partnering with academic partners, pharmaceutical and biotech companies to advance clinical research to develop cutting-edge gene therapies and surgical delivery devices to tackle some of the toughest eye diseases that steal the vision of millions of people around the world.

 

OUR PROMISE TO PATIENTS

– is big

Gyroscope was created to bring the right people and resources together to fundamentally change the lives of patients suffering from retinal diseases.

We know that our people, with their passion for patients, will drive to deliver on this promise.

越南河内5官方网站开奖结果 河内5分彩最快开奖结果下载 2022澳洲幸运5开奖结果 澳洲幸运10开奖直播 极速赛车现场开奖结果查- 赛车手机APP,全天人工 2022极速11选5 澳洲选五历史开奖-直播结 澳洲幸运5开奖结果官网- 幸运飞飞艇历史开奖:16